FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004335919> ?p ?o ?g. }

• W2004335919 endingPage "378" @default.
• W2004335919 startingPage "371" @default.
• W2004335919 abstract "Abstract Background: Antibodies against low-density lipoproteins (LDLs) that have been oxidized are associated with development of atherosclerotic lesions. In individuals infected with human immunodeficiency virus type 1 (HIV-1) with or without therapy, dyslipidemia and increased cardiovascular risk are observed. Methods: Serum levels of IgG antibodies against oxidized LDLs (IgG anti-oxLDL Abs) were determined by assay in 151 HIV-1-infected patients. Of these, 42 patients did not receive anti-retroviral therapy (ART-naïve), whereas 109 received highly active anti-retroviral therapy (HAART) consisting of lopinavir/ritonavir (LOP/r; n=50), efavirenz (EFV; n=30) and nevirapine (NVP; n=29) associated with nucleoside reverse transcriptase inhibitors. HIV-1 seronegative individuals (n=43) participated in the study. The following parameters were quantified: total cholesterol and its fractions, atherogenic indices (AIs), apolipoproteins A1 and B100, high sensitivity C-reactive protein, CD4 + and CD8 + T cells, and HIV-1-RNA. Results: Levels of IgG anti-oxLDL Abs were significantly higher (p<0.05) in the LOP/r group compared with the EFV and/or NVP and the seronegative group: median 0.32 (0.15, 0.58; 95% confidence interval) vs. 0.25 (0.13, 0.53) vs. 0.18 (0.04, 0.38), respectively. HIV-1-infected ART-naïve patients (n=42) presented antibodies levels similar to those observed for the LOP/r group, 0.33 (0.13, 0.63; p>0.05). The levels of IgG anti-oxLDL Abs correlated with an increase in AIs (r=0.216; p=0.036) and triglycerides (r=0.220; p=0.044) in the LOP/r group, and AIs in the ART-naïve group (r=0.300; p=0.046). Conclusions: Patients treated with LOP/r showed higher levels of IgG anti-oxLDL Abs compared with patients treated with EFV or NVP regimens, and these levels were associated with an increase in AIs." @default.
• W2004335919 created "2016-06-24" @default.
• W2004335919 creator A5005077485 @default.
• W2004335919 creator A5020660020 @default.
• W2004335919 creator A5024170031 @default.
• W2004335919 creator A5042142557 @default.
• W2004335919 creator A5058051100 @default.
• W2004335919 creator A5058308987 @default.
• W2004335919 creator A5080359779 @default.
• W2004335919 creator A5088535466 @default.
• W2004335919 date "2012-10-26" @default.
• W2004335919 modified "2023-10-18" @default.
• W2004335919 title "Serum levels of IgG antibodies against oxidized LDL and atherogenic indices in HIV-1-infected patients treated with protease inhibitors" @default.
• W2004335919 cites W1490762350 @default.
• W2004335919 cites W1966699435 @default.
• W2004335919 cites W1975249997 @default.
• W2004335919 cites W1976616659 @default.
• W2004335919 cites W1979192842 @default.
• W2004335919 cites W1979625649 @default.
• W2004335919 cites W1980811192 @default.
• W2004335919 cites W1984500566 @default.
• W2004335919 cites W1985122246 @default.
• W2004335919 cites W1989947634 @default.
• W2004335919 cites W1999791725 @default.
• W2004335919 cites W2003813742 @default.
• W2004335919 cites W2017298257 @default.
• W2004335919 cites W2028657303 @default.
• W2004335919 cites W2033049238 @default.
• W2004335919 cites W2059403223 @default.
• W2004335919 cites W2060139450 @default.
• W2004335919 cites W2076893109 @default.
• W2004335919 cites W2093271667 @default.
• W2004335919 cites W2116404316 @default.
• W2004335919 cites W2122650975 @default.
• W2004335919 cites W2122769971 @default.
• W2004335919 cites W2133649749 @default.
• W2004335919 cites W2133934785 @default.
• W2004335919 cites W2133955454 @default.
• W2004335919 cites W2148763385 @default.
• W2004335919 cites W2157138119 @default.
• W2004335919 cites W2159285468 @default.
• W2004335919 cites W2160125596 @default.
• W2004335919 cites W2163289904 @default.
• W2004335919 cites W2163451548 @default.
• W2004335919 cites W2166117607 @default.
• W2004335919 cites W2315380341 @default.
• W2004335919 cites W2329891072 @default.
• W2004335919 cites W2471505848 @default.
• W2004335919 cites W4240153861 @default.
• W2004335919 cites W4248098672 @default.
• W2004335919 doi "https://doi.org/10.1515/cclm-2012-0225" @default.
• W2004335919 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23241595" @default.
• W2004335919 hasPublicationYear "2012" @default.
• W2004335919 type Work @default.
• W2004335919 sameAs 2004335919 @default.
• W2004335919 citedByCount "12" @default.
• W2004335919 countsByYear W20043359192014 @default.
• W2004335919 countsByYear W20043359192015 @default.
• W2004335919 countsByYear W20043359192016 @default.
• W2004335919 countsByYear W20043359192018 @default.
• W2004335919 countsByYear W20043359192019 @default.
• W2004335919 countsByYear W20043359192021 @default.
• W2004335919 countsByYear W20043359192023 @default.
• W2004335919 crossrefType "journal-article" @default.
• W2004335919 hasAuthorship W2004335919A5005077485 @default.
• W2004335919 hasAuthorship W2004335919A5020660020 @default.
• W2004335919 hasAuthorship W2004335919A5024170031 @default.
• W2004335919 hasAuthorship W2004335919A5042142557 @default.
• W2004335919 hasAuthorship W2004335919A5058051100 @default.
• W2004335919 hasAuthorship W2004335919A5058308987 @default.
• W2004335919 hasAuthorship W2004335919A5080359779 @default.
• W2004335919 hasAuthorship W2004335919A5088535466 @default.
• W2004335919 hasConcept C126322002 @default.
• W2004335919 hasConcept C142462285 @default.
• W2004335919 hasConcept C159654299 @default.
• W2004335919 hasConcept C203014093 @default.
• W2004335919 hasConcept C2522874641 @default.
• W2004335919 hasConcept C2777182164 @default.
• W2004335919 hasConcept C2777351918 @default.
• W2004335919 hasConcept C2779130552 @default.
• W2004335919 hasConcept C2779298103 @default.
• W2004335919 hasConcept C2781432083 @default.
• W2004335919 hasConcept C2993143319 @default.
• W2004335919 hasConcept C71924100 @default.
• W2004335919 hasConcept C90924648 @default.
• W2004335919 hasConceptScore W2004335919C126322002 @default.
• W2004335919 hasConceptScore W2004335919C142462285 @default.
• W2004335919 hasConceptScore W2004335919C159654299 @default.
• W2004335919 hasConceptScore W2004335919C203014093 @default.
• W2004335919 hasConceptScore W2004335919C2522874641 @default.
• W2004335919 hasConceptScore W2004335919C2777182164 @default.
• W2004335919 hasConceptScore W2004335919C2777351918 @default.
• W2004335919 hasConceptScore W2004335919C2779130552 @default.
• W2004335919 hasConceptScore W2004335919C2779298103 @default.
• W2004335919 hasConceptScore W2004335919C2781432083 @default.
• W2004335919 hasConceptScore W2004335919C2993143319 @default.
• W2004335919 hasConceptScore W2004335919C71924100 @default.
• W2004335919 hasConceptScore W2004335919C90924648 @default.

• next